Farmsintez PAO

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

Div Yield, %

—

Shrs. gr., 5y

1.74%

Rev. gr., 5y

-12.10%

Revenues

Net income

CFO

Profile

Public Joint-Stock Company Pharmsynthez', a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez' has partnership with HiFiBiO Therapeutics Inks for the clinical development and commercialization of its SARS-CoV-2 neutralizing antibody in Russia. Public Joint-Stock Company Pharmsynthez' was founded in 1996 and is based in St. Petersburg, Russia.

URL

http://www.pharmsynthez.com/

IPO date

Nov 24, 2010

Employees

Domiciled in

Incorporated in

Valuation

No data to show